K. Peony Yu
2020
In 2020, K. Peony Yu earned a total compensation of $3.5M as Former Chief Medical Officer at FibroGen, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $459,000 |
|---|---|
| Option Awards | $1,201,950 |
| Salary | $612,000 |
| Stock Awards | $1,188,450 |
| Other | $51,364 |
| Total | $3,512,764 |
Yu received $1.2M in option awards, accounting for 34% of the total pay in 2020.
Yu also received $459K in non-equity incentive plan, $612K in salary, $1.2M in stock awards and $51.4K in other compensation.
Rankings
In 2020, K. Peony Yu's compensation ranked 3,299th out of 13,090 executives tracked by ExecPay. In other words, Yu earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,299 out of 13,090 | 75th |
Division Manufacturing | 1,280 out of 5,620 | 77th |
Major group Chemicals And Allied Products | 481 out of 2,253 | 79th |
Industry group Drugs | 417 out of 1,953 | 79th |
Industry Pharmaceutical Preparations | 311 out of 1,458 | 79th |
Pay ratio
| K. Peony Yu's Pay | $3,512,764 |
|---|---|
| Median Employee's Pay | $177,952 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of K. Peony Yu was $3,512,764.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of K. Peony Yu's pay to the pay of median employee was therefore 20 to one.
Source: SEC filing on April 13, 2021.
Yu's colleagues
We found seven more compensation records of executives who worked with K. Peony Yu at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Thane Wettig
FibroGen
Chief Commercial Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
Pat Cotroneo
FibroGen
Chief Financial Officer
2020
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2020
Christine Chung
FibroGen
Senior Vice President, China Operations
2020
James Schoeneck
FibroGen